oa SA Pharmaceutical Journal - Pfizer and Medicines for Malaria Venture advancing international research efforts in the fight against malaria : news

Volume 76, Issue 5
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



NEW YORK AND GENEVA - Pfizer Inc and Medicines for Malaria Venture (MVV) have signed an agreement that is designed to facilitate advancements in the battle against malaria, a disease that afflicts vulnerable populations in the developing world each year. Under the agreement, MMV will have access to the Pfizer library of novel chemical entities, in order to screen it for compounds that have the potential to be developed into new treatments for malaria.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error